Molecular Mechanisms of Atherosclerosis Hardback - 2004

After completing his training, Dr. Loscalzo joined the Harvard faculty and staff at Brigham and Women's Hospital in 1984. He ultimately rose to the rank of Associate Professor of Medicine, Chief of Cardiology at the West Roxbury Veterans Administration Medical Center, and Director of the Center for Research in Thrombolysis at Brigham and Women's Hospital. He joined the faculty of Boston University in 1994, first as Chief of Cardiology and, in 1997, Chair of Medicine.

Dr. Loscalzo is recognized as an outstanding cardiovascular scientist and clinician. He has received many awards including the Clinician-Scientist Award of the American Heart Association, the Research Career Development Award of the NIH, the George W. Thorn Award for Excellence in Teaching at Brigham and Women's Hospital, Educator of the Year Award in Clinical Medicine at Boston University, the Glaxo Cardiovascular Research Award, and election to the prestigious American Society for Clinical Investigation and Association of American Physicians. He has served on several NIH study sections and editorial boards, and has chaired the Gordon Conference on Thrombolysis. He served as Associate Editor of the prestigious New England Journal of Medicine for nine years, past Chair of the Cardiovascular Board of the American Board of Internal Medicine, past Chair of the Research Committee of the American Heart Association, and Chair of the Board of Scientific Counselors of the NHLBI. Dr. Loscalzo has been a Visiting Professor at many institutions and has authored or co-authored more than 450 scientific publications and 20 books. He holds 25 U.S. patents in the fields of nitric oxide and vascular biology. He is also the recipient of many grants from the NIH and industry for his work in the areas of vascular biology, thrombosis, and atherosclerosis over the past twenty years. Currently he is principal investigator of 4 active NIH grants including a Specialized Center of Research (SCOR) Grant in Ischemic Heart Disease from the NIH, now in its second cycle, and Chairs the Executive Committee of the NHLBI-sponsored Boston University Cardiovascular Proteomics Center. He is also Editor-in-Chief of the premier cardiovascular journal, Circulation.